主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RVMD
#513
Revolution Medicines, Inc. Common Stock
102.020
0
+0.79%
版块:
基础:
利润货币:
日范围
年范围
日变化
+0.79%
每月变动
+3.01%
6个月变化
+84.15%
年变化
+84.15%
前一天收盘价
101.220
0
Open
102.020
0
Bid
Ask
Low
102.020
0
High
102.020
0
交易量
349
市场
股票
医疗保健
RVMD
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
新闻
瑞银首次覆盖Revolution Medicines股票 因RAS抑制剂潜力给予买入评级
UBS assumes coverage on Revolution stock with buy rating on RAS inhibitor potential
RVMD Reports Wider-Than-Expected Q4 Loss, Issues 2026 Expense View
Piper Sandler上调Revolution Medicines目标价,看好其药物前景
Piper Sandler raises Revolution stock price target on drug confidence
Needham因成本上升下调Revolution Medicines目标价至145美元
Needham lowers Revolution stock price target to $145 on higher costs
富国银行因临床试验进展上调Revolution Medicines目标价
Wells Fargo raises Revolution stock price target on trial progress
Revolution Medicines, Inc. (RVMD) Q4 2025 Earnings Call Transcript
并购传闻后财报将至,Revolution Medicines成焦点
Revolution Medicines in spotlight as earnings loom after M&A chatter